In normal skeletal muscle fibers, dystrophin accumulates these experiments, we chose to study 10-week-old mdx4 cv at the cytoplasmic face of the sarcolemma where it associmice since at this developmental stage, muscles from ates with dystrophin-associated proteins (DAPs). Several these mice have already undergone several cycles of studies have recently shown that the neuronal isoform of degeneration-regeneration. Immunofluorescence experinitric oxide synthase (nNOS) is also located at the sarcoments performed on serial cross-sections revealed that lemma, and that this membrane localization is mediated approximately 50% of the dystrophin-positive fibers also through interactions of nNOS with one of the DAPs, namely exhibited significant levels of nNOS at their sarcolemma 2 ␣1-syntrophin. Since the lack of dystrophin in muscle fibers weeks following gene transfer with pRSV-dys. Similar from Duchenne muscular dystrophy patients and mdx mice results were obtained with pRSV-dyB indicating that exons is accompanied by an absence of sarcolemmal nNOS, we 17-48 of the dystrophin gene are not essential for the corexamined in the present study, whether dystrophin gene rect localization of nNOS in skeletal muscle fibers. Taken replacement would lead to the restoration of nNOS at its together with the recent demonstration that dystrophin appropriate subcellular location. To this end, tibialis gene transfer leads to significant physiological benefits our anterior muscles from mdx4 cv mice were directly injected results suggest that dystrophin gene therapy using fullwith plasmid DNA encoding either full-length (pRSV-dys) length or truncated dystrophin, also induces a rapid recovor mini-(pRSV-dyB; lacking exons 17-48) dystrophin. For ery of biochemical functions.
Introduction the dystrophin gene lead to the expression of a truncated Duchenne muscular dystrophy (DMD) is a fatal X-linked yet still functional protein which also accumulates at the neuromuscular disorder characterized by a progressive sarcolemma of muscle fibers. 9 loss of muscle mass and replacement of myofibers with Recently, the neuronal isoform of nitric oxide synthase connective and adipose tissues. 1 This disease is caused (nNOS) was detected in skeletal muscle fibers. 10 NOS is by the absence of dystrophin, a 427 kDa cytoskeletal prothe enzyme responsible for the conversion of l-arginine tein of the spectrin superfamily. In normal muscle, dysto NO, a well-known ubiquitous paracrine substance. The trophin is located at the cytoplasmic face of the sarcoprecise physiological role of NO in skeletal muscle lemma where it associates with a large complex of remains to be established, however, it has been shown proteins known as the dystrophin-associated proteins that NO may promote relaxation of skeletal muscle. 11, 12 (DAPs). 2, 3 At this site, dystrophin links the internal cytoSubsequent studies have in fact revealed that nNOS is skeleton of muscle fibers to the extracellular matrix. Such located at the sarcolemma of normal muscle fibers. 13 subcellular organization has led to the suggestion that Additional biochemical experiments have also recently dystrophin plays a key role in maintaining the integrity demonstrated that nNOS associates with the complex of and stability of the sarcolemma during repetitive cycles DAPs via interactions with ␣1-syntrophin. 14 Interestingly, of muscle contraction and relaxation. In fact, dystrophinsimilar to the loss of DAPs in muscle fibers from DMD deficient muscle fibers from both DMD patients and mdx patients and mdx mice, nNOS is also absent from the sarmice typically exhibit an increased fragility to osmotic colemma of dystrophin-deficient fibers. [13] [14] [15] shock 4 and mechanical stress. [5] [6] [7] [8] Less aggressive forms of Within the scope of gene therapy for DMD, it has the disease also occur and they are collectively termed already been shown that expression of mini-dystrophin Becker muscular dystrophy (BMD). BMD muscles disgene constructs into neonatal hindlimb 16 or adult diaphragm 8 muscles from mdx mice confers important protective effects against repetitive lengthening contractions important, none the less, to determine whether dystrotions to identify the injection sites and fibers that had been successfully transduced ( Figure 2A ). Serial cryostat phin gene replacement is accompanied by the appearance of nNOS at the sarcolemma in mdx mouse muscle fibers sections, adjacent to those containing ␤-galactosidasepositive muscle fibers, were then stained for the presence given that nitric oxide is a potent paracrine messenger exerting a variety of cellular effects in multiple of either dystrophin or nNOS using polyclonal antibodies (see Materials and methods). As shown in Figure 2B , tissues. 17, 18 In the present study, we have examined this issue by directly injecting plasmid DNA encoding either immunofluorescence experiments revealed the presence of dystrophin in these TA serial cross-sections. In several full-length or mini-dystrophin into tibialis anterior and diaphragm muscles of mdx4 cv mice, and by monitoring cases, we observed that the expression of ␤-galactosidase coincided with that of dystrophin thereby indicating that the presence of dystrophin and nNOS by immunofluorescence 2 weeks later. We chose to study 10-week-old these fibers were indeed transduced and not revertants (compare Figure 2A and B). Our results also showed that, mdx4 cv mice since at this developmental stage, skeletal muscles have already undergone several cycles of 2 weeks following full-length dystrophin gene transfer, degeneration-regeneration.
Results
We examined the consequence of mini-(pRSV-dyB) and full-length (pRSV-dys) dystrophin gene transfer on the localization and expression of nNOS in tibialis anterior (TA) muscle from mdx4 cv mice. The presence of dystrophin was first assessed in TA muscles from age-matched control C57Bl/6 mice and, as shown in Figure 1A , every fiber present in these cryostat sections displayed a strong dystrophin immunoreactivity. As expected, we also observed intense nNOS staining at the sarcolemma of these control muscle fibers ( Figure 1C ). By contrast, TA muscle fibers from mdx4 cv mice did not show any trace of dystrophin at their sarcolemma ( Figure 1B ). In fact, these experiments revealed, in agreement with previous reports, 8, 19 that the number of revertant fibers in these dystrophic muscles is extremely low, amounting to less than 1%. Similarly, immunofluorescence experiments failed to detect significant levels of nNOS in muscle fibers from mdx4 cv mice ( Figure 1D ). To determine the impact of dystrophin gene replacement on the sarcolemmal localization of nNOS in mdx4 cv mice, we co-injected pRSV-dys which encodes full-length dystrophin and a plasmid containing lacZ into TA muscles. Two weeks later, we examined the pattern of expression of ␤-galactosidase on alternate cryostat sec- cv (B and D) mice to strating that these fibers were successfully transduced.
Immunofluorescence detection of dystrophin and nNOS indicates that three of these fibres assess the presence of dystrophin and nNOS at the sarcolemma. As expected, these experiments demonstrated the presence of dystrophin (A) also express dystrophin (B) whereas only one was positive for nNOS (C). The arrow points to the fiber positive for ␤-galactosidase, dystrophin and and nNOS (C) in control fibers and the absence of these two proteins (B and D) in muscle fibers from mdx4
cv . Bar = 75 m. nNOS. Bar = 75 m.
some, but not all dystrophin-positive fibers expressed nNOS at their sarcolemma ( Figure 2C ). Quantitative analysis performed on these muscle sections revealed that of all the fibers expressing dystrophin, approximately half also displayed significant levels of sarcolemmal nNOS ( Figure 3 ). Furthermore, there appeared to be no correlation between expression of nNOS and central nucleation in transduced fibers.
In separate experiments, we used the same approach and directly injected into TA muscles from mdx4 cv mice, plasmid DNA encoding the 6.3 kb Becker-like human dystrophin gene. 9 Within injected areas of TA muscles characterized by the presence of ␤-galactosidase, we observed several clusters of muscle fibers that exhibited a strong level of mini-dystrophin expression ( Figure 4A and C). In these experiments, we also noted the presence of nNOS at the sarcolemma of approximately half of the In the light of these results, we also injected the diaphragm muscle from these mice with pRSV-dyB to determine whether expression of mini-dystrophin would induce expression of nNOS at the sarcolemma of transduced muscle fibers. This is particularly important since this thin respiratory muscle exhibits the same pathophysiological alterations characteristic of DMD muscles. [20] [21] [22] Immunofluorescence experiments revealed that diaphragm muscle fibers from C57Bl/6 mice displayed a high level of sarcolemmal nNOS ( Figure 5A ) whereas no immunoreactivity was observed in fibers from mdx4 cv mice ( Figure 5B ). In agreement with the data obtained with the TA muscle, we also noted that injected diaphragm muscle contained fibers that were positive for both dystrophin and nNOS (compare Figure 5C and D). 
Discussion
Several studies have recently shown that nNOS is enriched at the sarcolemma of normal skeletal muscle fibers and that, due to the loss of dystrophin, it was absent from both DMD and mdx mouse muscle fibers. [13] [14] [15] We have therefore examined in this study whether expression of full-length cularly important if gene therapy is to be considered as sarcolemma of transgenic mdx mice overexpressing minia therapeutic strategy for DMD. In our experiments, we dystrophin. The reason for this discrepancy is currently chose to study 10-week-old mdx4 cv mice, since at this far from being evident but is unlikely to be related to: (1) developmental stage, muscles of these mice have already the muscle under study, ie tibialis anterior versus quadriundergone several cycles of degeneration-regeneration; a ceps muscles; or (2) the mouse strain. condition prevailing in most DMD patients upon diagOne possibility that could account for these divergent nosis of the disease. On the basis of our immunofluofindings concerns the mini-dystrophin genes used in the rescence experiments using highly specific antibodies, we two studies. In our study, we used a dystrophin cDNA observed that expression of either full-length or minilacking exons 17-48 which reproduces identically the 6.3 dystrophin coincided with the presence of nNOS in kb Becker-like human mini-dystrophin gene. 9, 26 By conapproximately half of the transduced fibers. These results trast, Chao et al 24 studied a transgenic mouse line that therefore indicate that dystrophin gene replacement expressed a mini-dystrophin gene that also lacked exons leads, in addition to a functional recovery of muscle func-17-48 constructed by recombinant PCR using a pretion, 8, 16 to the rapid expression and correct localization of viously generated murine full-length dystrophin cDNA. 27 proteins normally associating with the complex of DAPs. Although a priori, this latter construct appears structurThese data are thus in agreement with those of Dunckley ally identical to ours, there may still be small differences, and colleagues 23 who previously showed that retrovirusparticularly in the region linking exons 16-49 in the mediated mini-dystrophin gene transfer in mdx mouse murine construct, which could affect nNOS localization hindlimb muscle was accompanied by the appearance of at the sarcolemma. Such interpretation, together with our the 43 kDa glycoprotein.
findings, is in fact coherent with the case of a BMD In a recent study performed with transgenic mdx mice patient with a large deletion of exons 13-41 in the specexpressing a transgene encoding the complete coding trin-like region of dystrophin, who showed, none the less, sequence for dystrophin, Chao and colleagues 24 reported significant nNOS immunoreactivity at the sarcolemma. 24 the presence of nNOS at the sarcolemma of all quadriceps Another possibility involves the transgenic mouse line muscle fibers. Our results are thus in good agreement used (12142CBVA line) in the study of Chao et al. 24 Prewith these findings, although we found that only vious work revealed, in fact, that skeletal muscles from approximately 50% of the transduced muscle fibers this line of mdx mice expressed five times the normal expressed both dystrophin and nNOS at their sarcolevel of dystrophin. 27 In normal muscle, the presence of lemma. At present, we can envisage several possibilities nNOS at the sarcolemma is thought to be mediated by to explain this minor discrepancy. The most straightfordirect binding of the enzyme to ␣1-syntrophin via interward interpretation is that skeletal muscle fibers are actions through PDZ domains.
14 However, overasynchronous with regard to expression and targeting of expression of dystrophin may saturate the sub-sarcoDAPs, including nNOS, to the sarcolemma following lemmal cytoskeletal network so that the PDZ domain of dystrophin gene transfer. In this case, it may simply be ␣1-syntrophin is no longer accessible to nNOS. As sugthat some fibers require an extended period of time for gested by Chao et al, 24 it is possible, under certain consynthesis of nNOS and transfer to its appropriate cellular ditions, that ␣1-syntrophin does not interact with dystrolocation. None the less, the recovery of nNOS levels that phin but rather, associates directly with the membrane we observed in 50% of transduced fibers 2 weeks followvia its pleckstrin homology (PH) domain. Since the first ing dystrophin gene transfer demonstrates, similarly to PH domain of ␣1-syntrophin overlaps with the PDZ what we have previously seen with the functional recovmotif, the direct association of ␣1-syntrophin with the ery, 8 that restoration of biochemical-associated functions membrane may disrupt the PDZ domain and hence, preis rapid. On the other hand, it is also possible that the clude further interactions of nNOS with ␣1-syntrophin permanent cellular damage induced by repeated cycles of through PDZ domains. In our study, the injection of plasmuscle degeneration-regeneration rendered some fibers mid DNA into muscles did not appear, on the basis of incapable of synthesizing de novo significant levels of immunofluorescence experiments, to lead to such overnNOS. This view, in fact, is supported by recent studies expression of mini-dystrophin in transduced muscle fibwhich demonstrated that in the case of neurogenic disers and thus, it has allowed for the proper assembly of eases, nNOS is absent from the sarcolemma despite the nNOS with the dystrophin complex. presence of dystrophin and of the dystrophin complex. 25 In this regard, it becomes important to note that in the These latter results therefore highlight a dissociation study of Chao et al, 24 the transgenic line expressing fullbetween dystrophin and nNOS under conditions where length dystrophin (862CAA line) showed a more modest muscle functions are perturbed and further indicate that level of dystrophin overexpression since it reached only the presence of dystrophin cannot by itself ensure the twice the level normally observed in control mouse appropriate localization of nNOS. This, in turn, would muscle. In contrast to the functional improvement still suggest that specific regulatory mechanisms participate observed in mdx mouse muscle overexpressing dystroin the assembly of the dystrophin complex at the sarcophin, 28 these results, taken together, indicate therefore lemma.
that overexpression of dystrophin may indeed have In our experiments, we also observed that direct injecsubtle negative effects on the recovery of biochemical tion of plasmid DNA encoding the Becker-like human functions. Accordingly, these findings indicate that the mini-dystrophin gene into mdx4 cv tibialis anterior muscle, amount of dystrophin expression in muscle may repinduced the appearance of nNOS at the sarcolemma in resent a more important parameter than previously approximately 50% of transduced fibers. Although this assumed, deserving careful planning if full functional value is identical to that obtained using full-length dysand biochemical recovery is to be envisaged following trophin (see above), these findings stand in sharp contrast to those of Chao et al 24 who failed to detect nNOS at the dystrophin gene transfer for DMD.
then thoroughly washed in PBS, dehydrated through a
Materials and methods
series of ethanol solutions, cleared in xylene and mounted using Permount. Dystrophin expression vector Recombinant plasmid DNA encoding the 6.3 kb Beckerlike human dystrophin mini-gene 9 or the full-length dysImmunofluorescent detection of dystrophin and nNOS trophin gene under the control of the Rous sarcoma virus Slides adjacent to those displaying ␤-galactosidasepromoter (pRSV-dyB and pRSV-dys, respectively) as well positive fibers were subjected to immunofluorescence as a plasmid containing the bacterial gene lacZ driven by experiments to detect the presence of dystrophin. Tissue the cytomegalovirus promoter (pCMV-lacZ) were presections were first incubated at room temperature in 0.5% pared by anion exchange chromatography using the BSA, 0.15% glycine in PBS (buffer A) for 15 min. NonspeQiagen mega-prep procedure (Chatsworth, CA, USA). cific binding was blocked by preincubation for 15 min The DNA was recovered by isopropanol precipitation, in buffer A supplemented with 5% normal goat serum. redissolved in sterile 0.1 m PBS (pH 7.4), divided into Sections were then incubated overnight at 4°C with a rabaliquots and stored at −20°C until required for injection.
bit polyclonal antibody raised against dystrophin from Torpedo marmorata 36 (diluted 1/500 in buffer A). Cy-3-Animals and surgical procedures conjugated donkey anti-rabbit IgG (Sigma, St Louis, MO, All experimental procedures involving injection of plas-USA; 1/500 in buffer A) was used as a secondary antimid DNA were performed on mdx4 cv mice 29 since these body. Following thorough washing of the secondary antimice have approximately 10-fold less revertant, dystrobody, the slides were mounted with CitiFluor phin-positive fibers in comparison with mdx mice (Ref.
(Canterbury, UK). 19; see also Ref. 8 ). Ten-week-old mice were used for Detection of nNOS was achieved on separate serial these studies and age-matched controls consisted of mice muscle sections using a rabbit polyclonal antibody raised from the C57Bl/6ScSn strain. Animals were housed in against the neuronal isoform of NOS (Santa Cruz Biotechgroups of two or three, maintained on a 12 h:12 h light:
nology, Santa Cruz, CA, USA). This antibody was diluted dark cycle, and provided with food and water ad libitum.
1/500 in buffer A and revealed using Cy-3-conjugated Care of the animals was in accordance with the guidedonkey anti-rabbit IgG. lines established by the Canadian Council for Animal Muscle sections were observed with a Zeiss Axiophot Care. All surgical procedures were approved by the Uniphotomicroscope (Oberkochen, Germany). Epifluorescversity of Ottawa Animal Care Committee.
ence illumination was used to visualize the fluorescent For injection, mdx4 cv mice were anesthetized with signal corresponding to dystrophin and nNOS. Kodak Tmethoxyflurane and the anterior surface of their hindMax black and white films (Newhaven, CT, USA) were limbs thoroughly shaved. Tibialis anterior (TA) muscles used for photodocumentation. were then co-injected with pCMV-lacZ and with either pRSV-dyB or pRSV-dys at concentrations of 2 g/l and Acknowledgements 4 g/l, respectively. Previous studies have shown that injection of two plasmids results in the co-expression of We thank Dr Verne M Chapman (Rosewell Park Cancer both proteins in a large proportion of muscle fibers.
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Institute, Buffalo, NY) for providing breeding pairs of the A total volume of 25 l of DNA solution containing the mdx4 cv mice and Jean Cartaud (Institut Jacques Monod, two plasmids was directly injected into the belly of TA Paris, France) for the generous gift of anti-dystrophin muscles. In some experiments, degeneration and regenerantibody. This work was partly supported by the Muscuation of TA muscles was induced by injecting 3 days lar Dystrophy Association of America. AD was supbefore DNA injection, 25 l of 10 −5 m cardiotoxin. 32 This ported by a post-doctoral fellowship from l'Association was done since regeneration is known to increase the Française contre les Myopathies. BJJ is a Scholar of the number of transduced muscle fibers. 33, 34 Two weeks folMedical Research Council of Canada. lowing DNA injection, the mice were killed with an overdose of sodium pentobarbital and the TA muscles quickly removed, frozen in melting isopentane precooled with
